Literature DB >> 30191034

Functional imaging of hepatocellular carcinoma.

Tim Ch Hoogenboom1,1, Mark Thursz2,2, Eric O Aboagye3,3, Rohini Sharma1,1.   

Abstract

Imaging plays a key role in the clinical management of hepatocellular carcinoma (HCC), but conventional imaging techniques have limited sensitivity in visualizing small tumors and assessing response to locoregional treatments and sorafenib. Functional imaging techniques allow visualization of organ and tumor physiology. Assessment of functional characteristics of tissue, such as metabolism, proliferation and stiffness, may overcome some of the limitations of structural imaging. In particular, novel molecular imaging agents offer a potential tool for early diagnosis of HCC, and radiomics may aid in response assessment and generate prognostic models. Further prospective research is warranted to evaluate emerging techniques and their cost-effectiveness in the context of HCC in order to improve detection and response assessment.

Entities:  

Keywords:  CT; MRI; PET; functional imaging; hepatocellular carcinoma; molecular imaging; radiomics; ultrasound

Year:  2016        PMID: 30191034      PMCID: PMC6095326          DOI: 10.2217/hep-2015-0005

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN: 2045-0923


  124 in total

Review 1.  Development of radiotracers for oncology--the interface with pharmacology.

Authors:  Rohini Sharma; Eric Aboagye
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

2.  Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial.

Authors:  Steven S Raman; Christopher Leary; David A Bluemke; Marco Amendola; Dushyant Sahani; Jeffrey D McTavish; Jeffrey Brody; Eric Outwater; Donald Mitchell; Douglas H Sheafor; Jeff Fidler; Isaac R Francis; Richard C Semelka; Kohkan Shamsi; Simone Gschwend; David R Feldman; Josy Breuer
Journal:  J Comput Assist Tomogr       Date:  2010 Mar-Apr       Impact factor: 1.826

3.  Characterization of primary and secondary malignant liver lesions from B-mode ultrasound.

Authors:  Jitendra Virmani; Vinod Kumar; Naveen Kalra; Niranjan Khandelwal
Journal:  J Digit Imaging       Date:  2013-12       Impact factor: 4.056

4.  The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.

Authors:  L James Wudel; Dominique Delbeke; David Morris; Michael Rice; Mary Kay Washington; Yu Shyr; C Wright Pinson; William C Chapman
Journal:  Am Surg       Date:  2003-02       Impact factor: 0.688

5.  Contrast-enhanced 3D ultrasound in the radiofrequency ablation of liver tumors.

Authors:  Edward Leen; Senthil Kumar; Shahid A Khan; Gavin Low; Keh Oon Ong; Paul Tait; Mike Averkiou
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

6.  Apparent diffusion coefficient quantification as an early imaging biomarker of response and predictor of survival following yttrium-90 radioembolization for unresectable infiltrative hepatocellular carcinoma with portal vein thrombosis.

Authors:  Nima Kokabi; Juan C Camacho; Minzhi Xing; Deqiang Qiu; Hiroumi Kitajima; Pardeep K Mittal; Hyun S Kim
Journal:  Abdom Imaging       Date:  2014-10

7.  MR elastography of liver tumors: preliminary results.

Authors:  Sudhakar K Venkatesh; Meng Yin; James F Glockner; Naoki Takahashi; Philip A Araoz; Jayant A Talwalkar; Richard L Ehman
Journal:  AJR Am J Roentgenol       Date:  2008-06       Impact factor: 3.959

Review 8.  Clinical applications of PET/MRI: current status and future perspectives.

Authors:  Felix Nensa; Karsten Beiderwellen; Philipp Heusch; Axel Wetter
Journal:  Diagn Interv Radiol       Date:  2014 Sep-Oct       Impact factor: 2.630

9.  Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial).

Authors:  D Strobel; K Seitz; W Blank; A Schuler; C Dietrich; A von Herbay; M Friedrich-Rust; G Kunze; D Becker; U Will; W Kratzer; F W Albert; C Pachmann; K Dirks; H Strunk; C Greis; T Bernatik
Journal:  Ultraschall Med       Date:  2008-10       Impact factor: 6.548

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.